Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab)2 fragment afelimomab in patients with sepsis and elevated interleukin-6 levels. - Panacek,E.A.; Marshall,J.C.; Albertson,T.E.; Johnson,D.H.; Johnson,S.; MacArthur,R.; Miller,M.; Barchuk,W.T.; Fischkoff,S.; Kaul,M.; Teoh,L.; Van Meter,L.; et al. (Crit Care Med, 2004)